These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2184486)
21. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report. Fiore S; Persichino L; Anticoli S; De Pandis MF Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468 [TBL] [Abstract][Full Text] [Related]
22. Sudden confusion with levodopa withdrawal. Lang AE Mov Disord; 1987; 2(3):223. PubMed ID: 3504551 [No Abstract] [Full Text] [Related]
25. Clozapine withdrawal symptoms in a Parkinson's disease patient. Zesiewicz TA; Borra S; Hauser RA Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085 [TBL] [Abstract][Full Text] [Related]
26. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome. Man SP Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association. Sahu H; Manjunath MB; Ray A; Vikram NK BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567175 [TBL] [Abstract][Full Text] [Related]
36. Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease. Hashimoto T; Tokuda T; Hanyu N; Tabata K; Yanagisawa N Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S25-30. PubMed ID: 12735912 [TBL] [Abstract][Full Text] [Related]
37. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease. Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413 [TBL] [Abstract][Full Text] [Related]
38. Fatal hyperpyrexia after withdrawal of levodopa. Sechi GP; Tanda F; Mutani R Neurology; 1984 Feb; 34(2):249-51. PubMed ID: 6538021 [TBL] [Abstract][Full Text] [Related]
39. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Mizuta E; Yamasaki S; Nakatake M; Kuno S Neurology; 1993 May; 43(5):1048-9. PubMed ID: 7605396 [TBL] [Abstract][Full Text] [Related]
40. L-dopa and frontal cognitive function in Parkinson's disease. Lange KW; Paul GM; Robbins TW; Marsden CD Adv Neurol; 1993; 60():475-8. PubMed ID: 8420173 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]